Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Retained Earnings (2016 - 2025)

Nephros has reported Retained Earnings over the past 16 years, most recently at -$143.1 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$143.1 million for Q4 2025, up 0.85% from a year ago — trailing twelve months through Dec 2025 was -$143.1 million (up 0.85% YoY), and the annual figure for FY2025 was -$143.1 million, up 0.85%.
  • Retained Earnings for Q4 2025 was -$143.1 million at Nephros, roughly flat from -$143.2 million in the prior quarter.
  • Over the last five years, Retained Earnings for NEPH hit a ceiling of $70000.0 in Q2 2021 and a floor of -$144.9 million in Q2 2024.
  • Median Retained Earnings over the past 5 years was -$143.2 million (2023), compared with a mean of -$121.1 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 100.05% in 2021 and later crashed 223273.44% in 2022.
  • Nephros' Retained Earnings stood at $64000.0 in 2021, then crashed by 223273.44% to -$142.8 million in 2022, then fell by 1.1% to -$144.4 million in 2023, then increased by 0.05% to -$144.3 million in 2024, then rose by 0.85% to -$143.1 million in 2025.
  • The last three reported values for Retained Earnings were -$143.1 million (Q4 2025), -$143.2 million (Q3 2025), and -$143.5 million (Q2 2025) per Business Quant data.